Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Galantamine for treatment-resistant schizophrenia.

× No keyword cloud information.

10 in total

Review 1. Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors: Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal: J Child Psychol Psychiatry Date: 2010-02-26 Impact factor: 8.982

Review 2. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Authors: G Mudo; N Belluardo; K Fuxe
Journal: J Neural Transm (Vienna) Date: 2006-08-17 Impact factor: 3.575

Review 3. Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

Authors: Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal: J Psychiatry Neurosci Date: 2006-11 Impact factor: 6.186

4. Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.

Authors: K Koda; Y Ago; K Yano; M Nishimura; H Kobayashi; A Fukada; K Takuma; T Matsuda
Journal: Br J Pharmacol Date: 2011-02 Impact factor: 8.739

Review 5. [Why do schizophrenic patients smoke?].

Authors: K Cattapan-Ludewig; S Ludewig; E Jaquenoud Sirot; M Etzensberger; F Hasler
Journal: Nervenarzt Date: 2005-03 Impact factor: 1.214

6. Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.

Authors: Ken Koda; Yukio Ago; Toshiyuki Kawasaki; Hitoshi Hashimoto; Akemichi Baba; Toshio Matsuda
Journal: Psychopharmacology (Berl) Date: 2007-10-03 Impact factor: 4.530

7. The effects of galantamine on psychopathology in chronic stable schizophrenia.

Authors: Robert R Conley; Douglas L Boggs; Deanna L Kelly; Robert P McMahon; Dwight Dickinson; Stephanie Feldman; M Patricia Ball; Robert W Buchanan
Journal: Clin Neuropharmacol Date: 2009 Mar-Apr Impact factor: 1.592

8. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

Authors: Michael A Dyer; Oliver Freudenreich; Melissa A Culhane; Gladys N Pachas; Thilo Deckersbach; Erin Murphy; Donald C Goff; A Eden Evins
Journal: Schizophr Res Date: 2008-03-05 Impact factor: 4.939

9. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice.

Authors: Morgane Thomsen; Gitta Wörtwein; Anders Fink-Jensen; David P D Woldbye; Jürgen Wess; S Barak Caine
Journal: Psychopharmacology (Berl) Date: 2007-02-20 Impact factor: 4.415

Review 10. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Authors: Enrique L M Ochoa; Jose Lasalde-Dominicci
Journal: Cell Mol Neurobiol Date: 2007-08 Impact factor: 5.046

10 in total